Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPI-Guided Norepinephrine Weaning in Vasoplegic Shock
NCT05922982Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Duration of norepinephrine administration at 72 hours. Started Sep 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05922982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05922982.